[Neonatal screening of glucose-6-phosphate dehydrogenase deficiency in umbilical cord blood]

F Kaddari1, M Sawadogo, J Sancho

  • 1Laboratoire d'immunologie-biochimie, Centre hospitalier Delafontaine, 93205 Saint-Denis.

Insights

Glucose-6-phosphate dehydrogenase (G6PD) deficiency screening is crucial for newborns, especially in at-risk populations. A new automated blood test using umbilical cord blood was developed to detect this common enzyme deficiency.

Area of Science:

  • Biochemistry
  • Genetics
  • Neonatology

Background:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme disorder globally.
  • It is a sex-linked genetic condition primarily affecting African, Mediterranean, and Far-Eastern populations.
  • Clinical manifestations include hemolytic anemia and neonatal jaundice.

Purpose of the Study:

  • To develop and validate an automated blood screening test for G6PD deficiency in neonates.
  • To establish normal reference values for G6PD and ASAT in umbilical cord blood.
  • To determine the genetic frequency of G6PD deficiency in newborns.

Main Methods:

  • Development of an automated assay for G6PD enzyme activity.
  • Utilization of red blood cell aspartate-amino-transferase (ASAT) as a reference enzyme to assess red blood cell age.
  • Analysis of 235 umbilical cord blood samples to calculate normal values and frequency.

Main Results:

  • Established normal ranges for G6PD, ASAT, and the G6PD/ASAT ratio in cord blood.
  • Determined the genetic frequency of G6PD deficiency to be 6% in males and 1% in females in 2002.
  • Successfully automated the G6PD assay for efficient neonatal screening.

Conclusions:

  • The developed automated test is suitable for neonatal screening of G6PD deficiency.
  • Neonatal screening for G6PD deficiency is essential, particularly in populations with a high prevalence.
  • The study provides baseline data on G6PD deficiency frequency in newborns.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...